Molecure S.A. (MOC.WA)

PLN 8.39

(-1.29%)

Operating Expenses Summary of Molecure S.A.

Molecure S.A.'s latest annual operating expenses in 2023 was 31.73 Million PLN , up 33.25% from previous year.
Molecure S.A.'s latest quarterly operating expenses in 2024 Q3 was 5.71 Million PLN , down -20.5% from previous quarter.
Molecure S.A. reported a annual operating expenses of 15.35 Million PLN in annual operating expenses 2022, up 39.69% from previous year.
Molecure S.A. reported a annual operating expenses of 10.99 Million PLN in annual operating expenses 2021, up 1.52% from previous year.
Molecure S.A. reported a quarterly operating expenses of 7.18 Million PLN for 2024 Q2, up 13.39% from previous quarter.
Molecure S.A. reported a quarterly operating expenses of 6.34 Million PLN for 2024 Q1, down -5.81% from previous quarter.

Annual Operating Expenses Chart of Molecure S.A. (2023 - 2015)

Historical Annual Operating Expenses of Molecure S.A. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	31.73 Million PLN	33.25%
2022	15.35 Million PLN	39.69%
2021	10.99 Million PLN	1.52%
2020	10.82 Million PLN	131.23%
2019	4.68 Million PLN	-5.86%
2018	4.97 Million PLN	100.78%
2017	2.47 Million PLN	0.12%
2016	2.47 Million PLN	234.15%
2015	740.44 Thousand PLN	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q3	5.71 Million PLN	-20.5%
2024 Q2	7.18 Million PLN	13.39%
2024 Q1	6.34 Million PLN	-5.81%
2023 Q2	5.15 Million PLN	36.21%
2023 FY	20.45 Million PLN	33.25%
2023 Q3	4.79 Million PLN	-6.9%
2023 Q4	6.73 Million PLN	40.4%
2023 Q1	3.78 Million PLN	-36.78%
2022 Q2	4.02 Million PLN	49.78%
2022 Q4	5.98 Million PLN	124.18%
2022 FY	15.35 Million PLN	39.69%
2022 Q1	2.68 Million PLN	-58.26%
2022 Q3	2.66 Million PLN	-33.64%
2021 Q4	6.43 Million PLN	325.48%
2021 FY	10.99 Million PLN	1.52%
2021 Q3	1.51 Million PLN	-17.99%
2021 Q2	1.84 Million PLN	52.96%
2021 Q1	1.2 Million PLN	-86.11%
2020 Q2	497.58 Thousand PLN	-45.6%
2020 Q3	737.27 Thousand PLN	48.17%
2020 Q4	8.67 Million PLN	1076.96%
2020 FY	10.82 Million PLN	131.23%
2020 Q1	914.66 Thousand PLN	-35.46%
2019 Q1	1.38 Million PLN	-30.14%
2019 Q4	1.41 Million PLN	44.81%
2019 Q3	978.73 Thousand PLN	8.97%
2019 Q2	898.15 Thousand PLN	-35.3%
2019 FY	4.68 Million PLN	-5.86%
2018 Q4	1.98 Million PLN	115.23%
2018 Q2	1.51 Million PLN	178.95%
2018 Q1	544.44 Thousand PLN	-65.26%
2018 FY	4.97 Million PLN	100.78%
2018 Q3	923.33 Thousand PLN	-39.2%
2017 Q1	456.67 Thousand PLN	-73.97%
2017 Q4	1.56 Million PLN	1396.02%
2017 FY	2.47 Million PLN	0.12%
2017 Q3	104.76 Thousand PLN	-69.93%
2017 Q2	348.41 Thousand PLN	-23.71%
2016 Q3	47.75 Thousand PLN	-90.39%
2016 Q4	1.75 Million PLN	3574.36%
2016 FY	2.47 Million PLN	234.15%
2016 Q1	496.95 Thousand PLN	0.0%
2016 Q2	496.95 Thousand PLN	0.0%
2015 FY	740.44 Thousand PLN	0.0%

Peer Operating Expenses Comparison of Molecure S.A.

Name	Operating Expenses	Operating Expenses Difference
Bioceltix S.A.	15.38 Million PLN	-106.246%
BIOTON S.A.	57.55 Million PLN	44.872%
Captor Therapeutics Spolka Akcyjna	79.91 Million PLN	60.296%
Mabion S.A.	59.52 Million PLN	46.691%
NanoGroup S.A.	7.82 Million PLN	-305.415%
Pharmena S.A.	-32.76 Million PLN	196.842%
Poltreg S.A.	15.47 Million PLN	-105.043%
Pure Biologics Spólka Akcyjna	29.14 Million PLN	-8.875%
Ryvu Therapeutics S.A.	4.73 Million PLN	-569.7%
Synthaverse S.A.	26.35 Million PLN	-20.401%
Urteste S.A.	5.96 Million PLN	-431.675%